This article appears in the following Journal of Antimicrobial Chemotherapy issue: The changing face of febrile neutropenia-from monotherapy to moulds to mucositis [View the issue table of contents]
Articles |
Why empirical therapy?
Department of Medicine, Institut Jules Bordet, 1000 Brussels, Belgium
* Tel: +32-254-13201; Fax: +32-054-13202; E-mail: jean.klastersky{at}bordet.be
Why empirical therapy? Because it works! Empirical antimicrobial therapy is a reasonable, pragmatic approach to limit the ominous threat of Gram-negative sepsis in febrile neutropenic cancer patients. Empirical treatment of occult fungal infection in patients with neutropenia and persistent fever, in spite of initial broad-spectrum antimicrobial coverage, is effective but the role of pre-emptive treatment remains to be established.
Keywords: neutropenic fever , infection in cancer , prophylaxis